Skip to main content
. 2023 Mar 1;13:3459. doi: 10.1038/s41598-023-30501-6

Table 3.

Odds ratios (with 95% CIs) of long and short sleep duration in hypnotic drug users and non-users in relation to demographic factors, habits, and medical history.

Variable Multivariate
Sleep duration Total P-value Hypnotic drug user P-value Non-Hypnotic drug user P-value
Age 6–9 1 1 1
 < 6 1.02 (1.02–1.03)  < 0.001 1.01 (0.99–1.04) 0.287 1.02 (1.02–1.03)  < 0.001
 > 9 1.01 (0.99–1.02) 0.151 0.99 (0.96–1.03) 0.778 1.01 (0.99–1.02) 0.163
Female 6–9 1 1 1
 < 6 0.99 (0.85–1.16) 0.899 1.07 (0.60–1.94) 0.812 0.99 (0.84–1.16) 0.884
 > 9 3.03 (2.18–4.20)  < 0.001 1.31 (0.56–3.11) 0.534 3.43 (2.39–4.91)  < 0.001
WSI 6–9 1 1 1
 < 6 0.99 (0.93–1.06) 0.862 1.07 (0.88–1.31) 0.482 0.98 (0.92–1.06) 0.649
 > 9 0.91 (0.82–1.02) 0.117 0.99 (0.75–1.31) 0.941 0.90 (0.80–1.02) 0.103
Education 6–9 1 1 1
 < 6 1.01 (1.00–1.03) 0.058 0.96 (0.92–1.00) 0.077 1.02 (1.01–1.04) 0.006
 > 9 0.96 (0.94–0.99) 0.007 0.93 (0.87–0.99) 0.034 0.97 (0.94–0.99) 0.037
BMI 6–9 1 1 1
 < 6 1.03 (1.02–1.04)  < 0.001 1.02 (0.98–1.06) 0.362 1.03 (1.02–1.05)  < 0.001
 > 9 0.98 (0.96–1.00) 0.091 0.99 (0.93–1.04) 0.608 0.98 (0.96–1.00) 0.014
Physical activity 6–9 1 1 1
 < 6 1.03 (1.02–1.04)  < 0.001 1.06 (1.03–1.10)  < 0.001 1.03 (1.02–1.04)  < 0.001
 > 9 0.83 (0.81–0.85)  < 0.001 0.82 (0.76–0.88)  < 0.001 0.83 (0.81–0.86)  < 0.001
Opium consumption 6–9 1 1 1
 < 6 1.04 (0.87–1.23) 0.663 1.41 (0.83–2.41) 0.208 1.01 (0.84–1.21) 0.910
 > 9 2.15 (1.59–2.92)  < 0.001 2.13 (1.01–4.46) 0.046 2.16 (1.54–3.02)  < 0.001
Alcohol consumption 6–9 1 1 1
 < 6 1.19 (0.97–1.45) 0.100 0.51 (0.21–1.20) 0.124 1.28 (1.04–1.58) 0.022
 > 9 0.59 (0.37–0.94) 0.027 0.34 (0.09–1.22) 0.099 0.66 (0.40–1.09) 0.106
Smoking 6–9 1 1 1
 < 6 0.95 (0.80–1.14) 0.603 0.85 (0.46–1.56) 0.593 0.97 (0.81–1.17) 0.758
 > 9 1.13 (0.80–1.59) 0.478 0.73 (0.31–1.71) 0.466 1.20 (0.82–1.75) 0.355
Diabetes 6–9 1 1 1
 < 6 1.03 (0.89–1.20) 0.669 0.91 (0.61–1.35) 0.647 1.06 (0.90–1.24) 0.491
 > 9 1.13 (0.89–1.44) 0.300 1.07 (0.61–1.86) 0.813 1.16 (0.89–1.51) 0.278
Thyroid 6–9 1 1 1
 < 6 0.91 (0.75–1.12) 0.376 0.65 (0.37–1.15) 0.139 0.96 (0.78–1.20) 0.735
 > 9 1.19 (0.88–1.61) 0.265 1.96 (1.04–3.67) 0.037 1.01 (0.70–1.44) 0.970
MI 6–9 1 1 1
 < 6 1.11 (0.78–1.57) 0.574 1.08 (0.47–2.46) 0.860 1.13 (077–1.69) 0.534
 > 9 1.66 (1.01–2.72) 0.045 1.94 (0.71–5.34) 0.199 1.56 (0.88–2.76) 0.131
CHD 6–9 1 1 1
 < 6 1.08 (0.87–1.34) 0.481 1.16 (0.73–1.85) 0.518 1.05 (0.82–1.34) 0.699
 > 9 0.85 (0.60–1.21) 0.361 0.70 (0.34–1.41) 0.311 0.91 (0.61–1.37) 0.659
Stroke 6–9 1 1 1
 < 6 0.68 (0.41–1.11) 0.124 1.25 (0.51–3.08) 0.626 0.55 (0.30–1.01) 0.054
 > 9 1.04 (0.55–1.98) 0.903 1.72 (0.56–5.30) 0.342 0.81 (0.35–1.83) 0.608
Depression 6–9 1 1 1
 < 6 1.17 (1.02–1.33) 0.023 1.45 (1.01–2.09) 0.049 1.14 (0.97–1.33) 0.104
 > 9 1.24 (0.99–1.54) 0.056 1.21 (0.71–2.07) 0.480 1.22 (0.94–1.58) 0.136
Dyslipidemia 6–9 1 1 1
 < 6 1.01 (0.89–1.15) 0.874 0.99 (0.64–1.52) 0.952 1.02 (0.88–1.17) 0.829
 > 9 0.95 (0.75–1.20) 0.657 1.41 (0.68–2.92) 0.358 0.89 (0.69–1.15) 0.377
Fatty liver 6–9 1 1 1
 < 6 1.16 (0.98–1.39) 0.092 1.16 (0.72–1.85) 0.541 1.15 (0.95–1.39) 0.153
 > 9 1.00 (0.73–1.39) 0.985 1.45 (0.74–2.82) 0.276 0.89 (0.61–1.30) 0.540
Lung disease 6–9 1 1 1
 < 6 1.33 (0.97–1.83) 0.076 1.77 (0.79–3.97) 0.167 1.27 (0.90–1.79) 0.179
 > 9 0.88 (0.50–1.58) 0.675 NA* 0.986 1.15 (0.64–2.07) 0.641
Hypertension 6–9 1 1 1
 < 6 1.01 (0.87–1.17) 0.923 0.94 (0.63–1.39) 0.751 1.02 (0.87–1.20) 0.787
 > 9 0.91 (0.71–1.17) 0.482 0.81 (0.45–1.43) 0.461 0.96 (0.73–1.27) 0.800

*Cannot be calculated because the number of people in this category is zero.

WSI: wealth score index, BMI body mass index, MI myocardial ischemia, CHD chronic heart diseases.